 Actinium Pharmaceuticals, Inc. NYSE AMERICAN: ATNM Actinium or the Company today announced the pricing of its previously announced public offering of 76,923,077 shares of its common stock or common stock equivalents in lieu thereof at a price to the public of 0.325 per share of common stock or common stock equivalent. The aggregate gross proceeds from this offering are expected to be approximately 25.0 million, before deducting placement agent fees and other estimated offering expenses payable by Actinium. The offering is expected to close on or about June 19, 2020, subject to satisfaction of customary closing conditions. 